Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $48
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $50 to $48.
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $50 to $48.